|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Relationships between low-density Iipoprotein particle size,plasma lipoproteins,and progression of coronary artery disease:The diabetes atherosclerosis intervention study(DAIS)显示文摘 | Vakkilainen J Steiner G Ansquer JC | 2003 | Circulation2003，107，13： | 1 |
| 2 | Relationships be- tween low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the diabetes athero- sclerosis intervention study ( DA IS) 显示文摘 | Vakkilainen J Steiner G Ansquer JC | 2003 | Circulation2003，107，13： | 1 |
| 3 | Relation- ships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease : the Diabetes Atherosclerosis Intervention Study (DAIS) 显示文摘 | Vakkilainen J Steiner G Ansquer JC | 2003 | Circulation2003，107，13： | 1 |
| 4 | Effect of fenofibrate on kidney func-tion:a6-week randomized crossover trial in healthy people显示文摘 | Ansquer JC Dalton RN Causse E | 2008 | Am J Kidney Dis2008，51，6： | 1 |
| 5 | Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo controlled study in type 2 diabetes:results from the Diabetes Atherosclerosis Intervention Study (DAIS) 显示文摘 | Ansquer JC Foucher C Rattier S | 2005 | Am J Kidney Dis2005，45，3： | 1 |
| 6 | Effect of fenofibrate on kidney function: a 6-week randomized crossover trial in healthy people 显示文摘 | Ansquer JC Dalton RN Causse E | 2008 | Am J Kidney Dis2008，51，6： | 1 |
| 7 | Fenofibrate reducesprogression to microalbuminuria over 3 years in a placebocontrolleddstuay in type 2 diabetes:results from the Diabetes Atherosclerosis Intervention Study (DAIS)显示文摘 | Ansquer JC Foucher C Rattier S et al | 2005 | Am J Kiadney Dis2005，45，3： | 1 |
| 8 | Efficacy and safety of coadministration of fenofibrate and ezetimibe compared with each as monotherapy in patients with type IIb dyslipidemia and features of the metabolic syndrome: a prospec- tive, randomized, double-blind, three-parallel arm, muhicenter, comparative study S显示文摘 | Ansquer JC Bekaert I Guy M | 2009 | Am J Cardiovasc Drugs2009，9，： | 1 |
| 9 | Fenofibrate reduces pro- gression to miem-albuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atheroselerosis Intervention Study (DAIS) 显示文摘 | Ansquer JC Foueher C Rattier S | 2005 | Am J Kidney Dis2005，45，3： | 1 |
| 10 | Efficacy and safety of coad- ministration of fenofihrate and ezetimibe compared with each as monotherapy in patients with type IIb dyslipidemia and features of the metabolic syndrome: a prospective, randomized, double blind, three-parallel arm, multicenter, comparative study 显示文摘 | Ansquer JC Bekaert I Guy M | 2009 | Am J Cardiovasc Drugs2009，9，2： | 1 |
| 11 | Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes :results from the Diabetes Atheroselerosis Intervention Study (DAIS)显示文摘 | Ansquer JC Foucher C Rattier S | 2005 | Am J Kidney Dis2005，45，48： | 1 |
| 12 | Efficacy and safety of coadministration of fenofibrate and ezetimibe compared with each as monotherapy in patients with type IIb dyslipidemia and features of the metabolic syndrome:a prospective,randomized,double-blind,three-parallel arm,multicenter,comparative study显示文摘 | Ansquer JC Bekaert I Guy M Hanefeld M Simon A Study Investigators | 2009 | Am J Cardiovasc Drugs2009，9，： | 1 |
| 13 | Relationships between low density lipoprotein particle size,plasma lipopro teins,and progression of coronary artery disease:the Diabe tes Atherosclerosis Intervention Study (DAIS)显示文摘 | Vakkilainen J Steiner G Ansquer JC | 2003 | Circulation2003，107，： | 1 |
| 14 | Relationships between low-density lipoprotein particle size, plasma lipopro- teins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS) 显示文摘 | Vakkilainen J Steiner G Ansquer JC | 2003 | Circulation2003，107，13： | 1 |
| 15 | Relationships between low- density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the diabetes atherosclerosis intervention study (DAIS) 显示文摘 | Vakkilainen J Steiner G Ansquer JC | 2003 | Circulation2003，107，： | 1 |
| 16 | Relationships between low-density lipoprotein particle size,plasma lipoproteins,and progression of coronary artery disease:the Diabetes Atherosclerosis Intervention Study (DAIS)显示文摘 | Vakkilainen J Steiner G Ansquer JC | 2003 | Circulation2003，107，13： | 1 |
| 17 | Relationships between low-density lipoprotein particle size,plasma lipoproteins,and progression of coronary artery disease:the Diabetes Atherosclerosis Intervention Study (DAIS)显示文摘 | Vakkilainen J Steiner G Ansquer JC | 2003 | Circulation2003，107，13： | 1 |
| 18 | Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: Results from the Diabetes Atherosclerosis Intervention Study (DAIS)显示文摘 | Ansquer JC Foucher C Rattier S | 2005 | American Journal of Kidney Diseases2005，45，3： | 1 |
| 19 | Fibrates and statins in the treatment of diabetic retinopathy显示文摘 | Ansquer JC Crimet D Foucher C | 2011 | Curr Pharm Biotechnol2011，12，： | 1 |
| 20 | Relationships between low-density lipoprotein partiele size, plasma lipoproreins, and progression of eoronary artery disease: the Diabetes Atheroselerosis Intervention Study (DAIS) 显示文摘 | Vakkilainen J Steiner G Ansquer JC | 2003 | Circulation2003，107，13： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员